Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Alzheimer's disease | R-HSA-1643685 | 0 | pyrvinium | 656630 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | pyrvinium | 656630 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | pyrvinium | 656630 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | pyrvinium | 656630 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | pyrvinium | 656630 | drug-path |
Homologous recombination | R-HSA-5685942 | map03440 | pyrvinium | 656630 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | pyrvinium | 656630 | drug-path |
Taste transduction | R-HSA-162582 | map04742 | pyrvinium | 656630 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | pyrvinium | 656630 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | pyrvinium | 656630 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | pyrvinium | 656630 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | pyrvinium | 656630 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | pyrvinium | 656630 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | pyrvinium | 656630 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | pyrvinium | 656630 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | oxaprozin | 4614 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | oxaprozin | 4614 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | oxaprozin | 4614 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | oxaprozin | 4614 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | oxaprozin | 4614 | drug-path |